• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·603976.SS
Share

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd Stocks

CN¥ 32.98Last Updated 14.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 737.83M

CN¥ 32.98
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. specializes in the research, development, manufacturing, and sale of various glass packaging solutions for the pharmaceutical industry across China. Their extensive product line includes medium borosilicate glass ampoule and injection bottles, low borosilicate tubular vials and ampoules, oral liquid vials, and screw-neck vials. The company also provides plastic flip-off and aluminum caps, as well as borosilicate and soda-lime glass control bottles. Established in 1988, the firm's headquarters are situated in Chongqing, China.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 603976.SS is 175 and suggests 442% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.10.2026 18:00

Elon Musk praised Micron, a manufacturer of AI memory chips. Should you buy its stock?

14.10.2026 17:50

Inflation in the U.S. rose at its fastest pace in five months. What can we expect from the Fed?

14.10.2026 17:20

China, TikTok, and Gen Z: A CNBC Analyst Sees a Good Opportunity in Crocs Stock

14.10.2026 16:53

Bank of America reported a sharp drop in profits following a $1.2 billion fine

14.10.2026 16:27

Starting in July 2027, it will not be possible to enter Kazakhstan without an electronic permit

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026